Evidence of direct interactions between the CC-chemokines CCL3, CCL4 and CCL5 and Leishmania promastigotes

被引：3
|
作者：
Roychoudhury, Kaushik
Dasgupta, Biplab
Sen, Pradip
Laskay, Tamas
Solbach, Werner
De, Tripti
Roy, Syamal [1 ]
机构：
[1] Indian Inst Chem Biol, Kolkata 700032, W Bengal, India
[2] Med Univ Lubeck, D-23538 Lubeck, Germany
来源：
MOLECULAR AND BIOCHEMICAL PARASITOLOGY | 2006年 / 150卷 / 02期
关键词：
Leishmania; chemokine; binding; chemotaxis;
D O I：
10.1016/j.molbiopara.2006.08.009
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：374 / 377
页数：4
相关论文
共 50 条
  • [21] Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells
    Jing, H
    Vassiliou, E
    Ganea, D
    JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 74 (05) : 868 - 879
  • [22] Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells
    Jing, H
    Vassiliou, E
    Ganea, D
    FASEB JOURNAL, 2003, 17 (07): : C140 - C140
  • [23] Immune Response CC Chemokines, CCL5 and CCL2 Are Associated with Pulmonary Sarcoidosis.
    Hashemi, N.
    Weigt, S. S.
    Xue, Y. Y.
    Palchevskiy, V.
    Huang, C.
    Zisman, D. A.
    Fishbein, M.
    Lynch, J. P., III
    Elashoff, R. M.
    Belperio, J. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [24] Chemokines CCL3, CCL4 and chemokine receptor CCR5 in HIV-1-infected women with complicated anamnesis
    Chernyshov, V. P.
    Podolsky, V. V.
    Dons'koi, B. V.
    Kostyuchyk, A. A.
    Podolsky, V. V.
    IMMUNOLOGY, 2012, 137 : 514 - 514
  • [25] Engagement of NKp30 on Vδ1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication
    Hudspeth, Kelly
    Fogli, Manuela
    Correia, Daniel V.
    Mikulak, Joanna
    Roberto, Alessandra
    Della Bella, Silvia
    Silva-Santos, Bruno
    Mavilio, Domenico
    BLOOD, 2012, 119 (17) : 4013 - 4016
  • [26] Alkannin inhibits CCL3 and CCL5 production in human periodontal ligament cells
    Hosokawa, Yoshitaka
    Hosokawa, Ikuko
    Shindo, Satoru
    Ohta, Yoshihiro
    Ozaki, Kazumi
    Matsuo, Takashi
    CELL BIOLOGY INTERNATIONAL, 2016, 40 (12) : 1380 - 1385
  • [27] CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment
    Bandinelli, F.
    Del Rosso, A.
    Gabrielli, A.
    Giacomelli, R.
    Bartoli, F.
    Guiducci, S.
    Matucci-Cerinic, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (02) : S44 - S49
  • [28] CCL2, CCL3 and CCL4 gene polymorphisms in pulmonary tuberculosis patients of South India
    Singh, B.
    Chitra, J.
    Selvaraj, P.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2014, 41 (02) : 98 - 104
  • [29] Role of the chemokines CCL3/MIP-1α and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice
    Barcelos, Luciola S.
    Coelho, Amanda M.
    Russo, Remo C.
    Guabiraba, Rodrigo
    Souza, Adriano L. S.
    Bruno-Lima, Guilherme, Jr.
    Proudfoot, Amanda E. I.
    Andrade, Silvia P.
    Teixeira, Mauro M.
    MICROVASCULAR RESEARCH, 2009, 78 (02) : 148 - 154
  • [30] Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells
    Daniel S Pharoah
    Hemlata Varsani
    Richard W Tatham
    Katy R Newton
    Wilco de Jager
    Berent J Prakken
    Nigel Klein
    Lucy R Wedderburn
    Arthritis Research & Therapy, 8
12345